echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Hainan Lecheng Pioneer District's first global simultaneous application of innovative drugs was approved for use.

    Hainan Lecheng Pioneer District's first global simultaneous application of innovative drugs was approved for use.

    • Last Update: 2020-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to reports, Riptini was approved abroad after the listing, the first district launched the introduction process, less than two months to achieve the landing.
    present, the relevant hospitals in the advance area have set up a special medical team to provide follow-up protection for the Riptini project, and comprehensively collect data on the clinical use of patients, file cards, in order to gradually optimize clinical applications.
    In March this year, the Interim Measures for the Administration of the Use of Imported Drugs Away from the Advance Zone in the International Medical Tourism Advance Zone of Boao Lecheng, Hainan Province, were issued, allowing patients to take imported drugs out of the advance zone for their own use only and a small number of oral clinically urgent needs to be taken out of the advance zone.
    the head of the Hong Kong Advance District Authority said that with the new policy of Hainan Free Trade Port, Riptini had been able to speed up the approval of the use of the advance zone to serve domestic patients.
    now have patients applying to take away from the use of Riptini, marking the drug will become the first special approval to take away from the park after the release of the Hainan Free Trade Port Construction Master Plan.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.